Acadia Healthcare Rises Even as New Legal Issue Emerges
Acadia Healthcare shares rose 4.76% to $24.42 Tuesday, outpacing major indexes, with 2.3 million shares traded. First-quarter revenue climbed 7.6% to $828.8 million and adjusted EBITDA reached $144.2 million. The company faces legal costs, payer denials, and a recent jury award against a subsidiary. Analyst ratings remain mixed, with price targets ranging from $13 to $39.
